Showing results (1-10 of 262) with videos related to
Sort By:
Pageof 27
Clinical and Experimental Rheumatology|November 4, 2010
Use of methotrexate in ANCA-associated vasculitidesE Reinhold-Keller, K de GrootZeitschrift Fur Rheumatologie|February 3, 2009
[Wegener's granulomatosis and microscopic polyangiitis]K de Groot, E Reinhold-KellerClinical Nephrology|February 24, 2001
Development and validation of a disease extent index for Wegener's granulomatosisK de Groot, W L Gross, K Herlyn, et al.The Journal of Rheumatology|March 28, 1998
Induction of remission in Wegener's granulomatosis with low dose methotrexateK de Groot, M Mühler, E Reinhold-Keller, et al.Clinical and Experimental Immunology|July 1, 1995
Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulinC Richter, A Schnabel, E Csernok, et al.QJM : Monthly Journal of the Association of Physicians|January 1, 1996
Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of diseaseE Reinhold-Keller, K De Groot, H Rudert, et al.Archives of Neurology|August 31, 2001
Standardized neurologic evaluations of 128 patients with Wegener granulomatosisK de Groot, D K Schmidt, A C Arlt, et al.Arthritis and Rheumatism|December 1, 1996
Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazoleK de Groot, E Reinhold-Keller, E Tatsis, et al.Arthritis and Rheumatism|May 19, 2000
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patientsE Reinhold-Keller, N Beuge, U Latza, et al.Clinical and Experimental Rheumatology|October 3, 2001
Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literatureE Reinhold-Keller, K de Groot, K Holl-Ulrich, et al.Pageof 27